Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program
Go back to Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program| (NASDAQ: QNRX) | Delayed: 4.65 +0.03 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.62 | 52 Week High | $ | |||
| Open | $4.63 | 52 Week Low | $ | |||
| Day High | $4.68 | P/E | N/A | |||
| Day Low | $4.50 | EPS | $ | |||
| Volume | 6,556 | |||||

